Rayonier Advanced Materials (RYAM) opened 2026 with Q1 revenue of US$319 million and a basic EPS loss of US$1.21, alongside trailing 12 month revenue of about US$1.4 billion and a basic EPS loss of US$7.08. Over recent quarters the company has seen revenue move from US$422.5 million in Q4 2024 to US$355.9 million in Q1 2025, US$340.0 million in Q2 2025, US$352.8 million in Q3 2025, US$417.5 million in Q4 2025 and now US$319 million in Q1 2026, while quarterly basic EPS losses have ranged between roughly US$0.07 and US$5.48 over that stretch. For investors, this latest print keeps the spotlight firmly on how quickly management can stabilize margins and contain losses.

See our full analysis for Rayonier Advanced Materials.

With the numbers on the table, the next step is to set these results against the widely followed narratives around Rayonier Advanced Materials to see which views hold up and which are pressured by the latest margin picture.

Losses widen again with US$81 million Q1 hit

• Q1 2026 net loss excluding extra items was US$81 million on US$319 million of revenue, versus US$21.5 million loss on US$417.5 million of revenue in Q4 2025, and the trailing 12 month loss sits at US$474.2 million on US$1.4b of revenue.
• Bears focus on this pattern of losses getting larger over time, with trailing 12 month losses reported as having grown at an average rate of 57% per year, and argue that this trend questions how quickly the business can improve margins even as management talks about cost controls and mix improvements.
  • The Q2 2025 loss of US$366.3 million was a particularly heavy quarter and feeds into the current 12 month net loss of US$474.2 million, which skeptics view as a signal that volatility in profitability has been high.
  • Against that backdrop, the Q1 2026 basic EPS loss of US$1.21 compared with a trailing 12 month EPS loss of US$7.08 reinforces the bearish view that, so far, reported earnings have not aligned with the improvement path described in more optimistic narratives.

Stay with this cautious thread by looking at how ongoing losses line up against the more pessimistic long term forecasts in the full bearish narrative 🐻 Rayonier Advanced Materials Bear Case.

Cash runway under a year heightens risk

• The company is reported to have less than one year of cash runway while remaining unprofitable over the last 12 months, and analysts do not expect a return to profitability over the next three years.
• Critics highlight that limited runway combined with a widening 12 month loss of US$474.2 million increases financing and execution risk, even though bears still model revenue growing around 4.7% per year and margins improving from about a 29% loss today to positive territory in their long range scenarios.
  • In Q1 2026 alone, the loss of US$81 million compares with a full year 12 month loss of US$474.2 million, so any misstep on cost control or pricing could make that cash runway even tighter than modeled.
  • At the same time, bears expect earnings to move from a loss of roughly US$423 million today to US$178.4 million profit by 2029, which some readers may view as an ambitious shift given the current cash and loss profile.

Low 0.5x P/S against US$9.82 share price

• On the trailing 12 month revenue base of US$1.4b, the stock trades on a P/S of 0.5x, which is below the US Chemicals industry at 1.1x and peer average at 0.9x, while the current share price is US$9.82 against an analyst consensus target of US$14.50 and a DCF fair value of about US$59.55.
• Supporters of a more optimistic view point to this discount against both the consensus target and DCF fair value, arguing that if analysts are right about revenue growing around 2.8% per year and margins improving from about a 29% loss to a 12.6% profit by 2029, today’s low P/S multiple and gap to US$14.50 leave room for re rating if execution improves.
  • The trailing revenue line of roughly US$1.4b paired with a 0.5x P/S multiple contrasts with the industry’s 1.1x, which bullish investors see as the market pricing in a lot of the current loss profile already.
  • Consensus expectations for earnings to move from about a US$425.2 million loss today to US$200.6 million profit by 2029 are a key pillar of that bullish stance and help explain why the target price of US$14.50 sits well above the current US$9.82 share price.

If you want to see how these expectations build into a full optimistic thesis, including forecasts behind those margin and revenue targets, check out the detailed bull case 🐂 Rayonier Advanced Materials Bull Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Rayonier Advanced Materials on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Mixed messages from the numbers and narratives so far? Take a closer look at the data yourself and decide how compelling the balance of risks and rewards really is with 2 key rewards and 3 important warning signs.

See What Else Is Out There

With a trailing 12 month loss of US$474.2 million, widening quarterly losses and less than a year of cash runway, Rayonier Advanced Materials carries elevated financial risk.

If you want ideas where balance sheets look sturdier and earnings pressure is less intense, start comparing alternatives now with the solid balance sheet and fundamentals stocks screener (45 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.